...
首页> 外文期刊>Respiration: International Review of Thoracic Diseases >Left ventricular geometry in patients with obstructive sleep apnea coexisting with treated systemic hypertension.
【24h】

Left ventricular geometry in patients with obstructive sleep apnea coexisting with treated systemic hypertension.

机译:阻塞性睡眠呼吸暂停合并系统性高血压的患者左室几何形状。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Left ventricular (LV) hypertrophy is a common consequence of systemic hypertension (SH) and obstructive sleep apnea (OSA). However, little is known about the degree of LV involvement in patients with OSA coexisting with treated SH. OBJECTIVES: Our study was designed in order to assess the prevalence of distinct types of LV geometry in treated hypertensive OSA patients. METHODS: PATIENTS: 183 patients with treated SH were enrolled to the study. Group 1 consisted of 38 patients with newly-diagnosed OSA and ineffectively treated SH. The remaining 145 patients with effectively treated SH were divided into three groups: group 2 - 70 patients with newly-diagnosed OSA, group 3 - 31 patients with OSA treated with continuous positive airway pressure (CPAP), and group 4 - 44 patients without OSA.Overnight sleep studies and M-mode echocardiography were performed. RESULTS: LV mass index did not differ between the study groups. Mean values of LV end-diastolic diameter (LVED) were 55.4 +/- 6.8 mm in group 1 and 53.6 +/- 6.9 mm in group 2 and were significantly increased in comparison to subjects treated with CPAP and controls (49.8 +/- 6.8 mm and 50.1 +/- 64.7 mm, respectively; p = 0.001). LVED correlated positively with the apnea-hypopnea index and desaturation index. LV eccentric hypertrophy was the commonest type of LV geometry in newly-diagnosed OSA patients. CONCLUSIONS: The major finding of our study is the predominance of LV eccentric hypertrophy in newly-diagnosed OSA patients. We suggest that a relatively moderate degree of LV involvement in hypertensive OSA patients may depend on the cardioprotective effect of concomitant antihypertensive therapy, ameliorating OSA-dependent neurohumoral abnormalities.
机译:背景:左心室肥大是系统性高血压(SH)和阻塞性睡眠呼吸暂停(OSA)的常见结果。然而,关于OSA与治疗的SH并存的患者的LV受累程度知之甚少。目的:本研究旨在评估高血压OSA患者中不同类型的LV几何的患病率。方法:患者:183名接受过SH治疗的患者入选了该研究。第一组由38例新诊断为OSA且治疗无效的SH患者组成。其余145例有效治疗SH的患者分为三组:第2 – 70例新诊断为OSA的患者,第3 – 31例通过持续气道正压通气(CPAP)治疗的OSA的患者和第4-44例无OSA的患者进行了整夜睡眠研究和M型超声心动图检查。结果:各研究组的左心室质量指数无差异。第1组的LV舒张末期直径(LVED)的平均值为55.4 +/- 6.8 mm,第2组的平均值为53.6 +/- 6.9 mm,与经CPAP和对照组治疗的受试者相比,显着增加(49.8 +/- 6.8毫米和50.1 +/- 64.7毫米; p = 0.001)。 LVED与呼吸暂停低通气指数和去饱和指数呈正相关。左心室肥大是新诊断的OSA患者中最常见的左心室几何类型。结论:本研究的主要发现是在新诊断的OSA患者中左室偏心肥大。我们建议在高血压OSA患者中相对中等程度的LV介入可能取决于同时进行的降压治疗的心脏保护作用,从而改善OSA依赖性神经体液异常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号